Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients

OBJECTIVE: The use of once-daily dual-release HC (DR-HC) in primary adrenal insufficiency (PAI) is often associated with benefits in metabolic parameters when compared to immediate-release HC (IR-HC). In this study, we evaluated the effects on clinical, biochemical and metabolic parameters of switch...

Descripción completa

Detalles Bibliográficos
Autores principales: Delle Cese, Francesca, Corsello, Andrea, Cintoni, Marco, Locantore, Pietro, Pontecorvi, Alfredo, Corsello, Salvatore Maria, Paragliola, Rosa Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883639/
https://www.ncbi.nlm.nih.gov/pubmed/33597926
http://dx.doi.org/10.3389/fendo.2020.610904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883639/
https://www.ncbi.nlm.nih.gov/pubmed/33597926
http://dx.doi.org/10.3389/fendo.2020.610904

Ejemplares similares